N Skordis1,2,3, C Shammas1, A A P Phedonos1, A Kyriakou2,4, M Toumba5, V Neocleous1, L A Phylactou6. 1. Department of Molecular Genetics, Function and Therapy, The Cyprus Institute of Neurology and Genetics, P.O. Box 23462, 1683, Nicosia, Cyprus. 2. Division of Pediatric Endocrinology, Paedi Center for Specialized Pediatrics, Nicosia, Cyprus. 3. St George's, University of London Medical School Programme at the University of Nicosia, Nicosia, Cyprus. 4. Developmental Endocrinology Research Group, Royal Hospital for Sick Children, University of Glasgow, Glasgow, UK. 5. Iasis Hospital, 8036, Paphos, Cyprus. 6. Department of Molecular Genetics, Function and Therapy, The Cyprus Institute of Neurology and Genetics, P.O. Box 23462, 1683, Nicosia, Cyprus. laphylac@cing.ac.cy.
Abstract
OBJECTIVES: To seek evidence on the prevalence of CYP21A2 genetic defects and consequences in girls with premature adrenarche (PA). METHODS: The study included 59 girls diagnosed with PA. Direct DNA sequencing and MLPA analysis were performed to identify mutations in CYP21A2 gene. RESULTS: Twelve girls were diagnosed with non-classic congenital adrenal hyperplasia (NC-CAH) based on stimulated 17-hydroxyprogesterone (17-OHP) levels and the presence of two mutations in CYP21A2, 19 were heterozygotes. The most frequent mutations detected were the mild p.Val281Leu and p.Pro453Ser. Higher levels of mean stimulated 17-OHP were found in the carriers of the p.Val281Leu mutation. The detection rate for two CYP21A2 mutations was higher in girls with PA than in adult females with hyperandrogenemia in our studied population. A notable increased allelic frequency for the known p.Asn493Ser polymorphism was observed in the pool of the 28 girls with PA in whom no mutation was identified. CONCLUSIONS: In girls with PA, the frequency of the underlying CYP21A2 genetic defects is similar to that observed in other populations. The carrier status is likely a contributing factor in the genotype-phenotype correlation in NC-CAH. However, polymorphisms and other genes may be implicated in the clinical manifestation of the disease.
OBJECTIVES: To seek evidence on the prevalence of CYP21A2genetic defects and consequences in girls with premature adrenarche (PA). METHODS: The study included 59 girls diagnosed with PA. Direct DNA sequencing and MLPA analysis were performed to identify mutations in CYP21A2 gene. RESULTS: Twelve girls were diagnosed with non-classic congenital adrenal hyperplasia (NC-CAH) based on stimulated 17-hydroxyprogesterone (17-OHP) levels and the presence of two mutations in CYP21A2, 19 were heterozygotes. The most frequent mutations detected were the mild p.Val281Leu and p.Pro453Ser. Higher levels of mean stimulated 17-OHP were found in the carriers of the p.Val281Leu mutation. The detection rate for two CYP21A2 mutations was higher in girls with PA than in adult females with hyperandrogenemia in our studied population. A notable increased allelic frequency for the known p.Asn493Ser polymorphism was observed in the pool of the 28 girls with PA in whom no mutation was identified. CONCLUSIONS: In girls with PA, the frequency of the underlying CYP21A2genetic defects is similar to that observed in other populations. The carrier status is likely a contributing factor in the genotype-phenotype correlation in NC-CAH. However, polymorphisms and other genes may be implicated in the clinical manifestation of the disease.
Authors: V Dolzan; J Sólyom; G Fekete; J Kovács; V Rakosnikova; F Votava; J Lebl; Z Pribilincova; S M Baumgartner-Parzer; S Riedl; F Waldhauser; H Frisch; M Stopar-Obreza; C Krzisnik; T Battelino Journal: Eur J Endocrinol Date: 2005-07 Impact factor: 6.664
Authors: T A Bachega; A E Billerbeck; J A Marcondes; G Madureira; I J Arnhold; B B Mendonca Journal: Clin Endocrinol (Oxf) Date: 2000-05 Impact factor: 3.478
Authors: S Menabò; A Balsamo; L Baldazzi; M Barbaro; A Nicoletti; V Conti; P Pirazzoli; A Wedell; A Cicognani Journal: J Endocrinol Invest Date: 2011-04-26 Impact factor: 4.256
Authors: Vassos Neocleous; Pavlos Fanis; Meropi Toumba; Alexia A P Phedonos; Michalis Picolos; Elena Andreou; Tassos C Kyriakides; George A Tanteles; Christos Shammas; Leonidas A Phylactou; Nicos Skordis Journal: Int J Endocrinol Date: 2017-04-12 Impact factor: 3.257